{"filings":[{"id":746529,"accession_number":"0001193125-26-248230","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2026-05-29T20:05:15+00:00","items":["5.02","5.08","8.01"],"status":"ready","headline":"LENSAR appoints Michael A. Rossi as Interim CFO; annual meeting set for Aug 4, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael A. Rossi appointed Interim CFO effective May 29, 2026, via consulting agreement with Monomoy Advisors at $375/hour.","Rossi previously CFO at Access Vascular, ConcertAI, and Harvard Bioscience (Nasdaq: HBIO).","Annual meeting scheduled for Aug 4, 2026, held virtually; record date June 10, 2026.","Stockholder proposals and director nominations due by June 8, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92072,"accession_number":"0001193125-26-213268","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LENSAR Q1 revenue down 5% to $13.4M; net income $36.3M on $23.9M warrant gain and $10M merger termination income","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Recurring revenue rose 9% YoY to $12.6M (94% of total); total system sales fell to $836K from $2.6M.","Net income $36.3M ($1.56 basic EPS) vs net loss $27.3M ($2.32 loss) in Q1 2025; adjusted EBITDA loss $0.3M.","Placed 7 ALLY systems in Q1; total installed base 440 (up 12% YoY); backlog of 11 pending installations.","Selling, general & admin expenses down 77% due to absence of $4.4M acquisition costs; R&D flat at $1.4M.","CEO cites terminated Alcon transaction uncertainty as cause of system placement slowdown; expects recovery."],"consensus_eps_estimate":null,"consensus_eps_actual":0.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":13428000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92071,"accession_number":"0001193125-26-157105","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2026-04-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"LENSAR CFO Thomas R. Staab II to resign effective May 8, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Thomas R. Staab II notified company of resignation on April 10, 2026, effective May 8, 2026.","Resignation is to pursue other professional opportunities; not due to any disagreement with company.","Staab will continue as principal financial officer through Transition Date; search for new CFO underway."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":102613,"accession_number":"0001193125-26-133153","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LENSAR Q4 revenue $16.0M (-4% YoY); recurring revenue up 17% to $12.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss narrowed to $1.5M ($0.12/sh) from $18.7M loss a year ago, largely on warrant liability fair-value change.","Full-year revenue $58.4M (+9%); recurring revenue $46.3M (+15%) driven by 22% increase in worldwide procedures.","ALLY installed base reached ~200 systems (+48% YoY); 15 placed in Q4, 13 systems in backlog.","SG&A rose $3.5M to $10.3M, primarily from $3.5M in costs tied to the terminated Alcon merger.","Procedure volume 54,756 in Q4 (+20% YoY) and 206,014 for FY2025 (+22% YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":13428000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":102612,"accession_number":"0001193125-26-109458","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2026-03-17T23:59:59+00:00","items":["1.01","1.02","7.01","9.01"],"status":"ready","headline":"LENSAR terminates merger with Alcon; retains $10M deposit; FTC intended to challenge deal","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Merger agreement terminated effective March 16, 2026; FTC intended to seek injunction.","LENSAR retains $10.0M deposit from Alcon under the Termination Agreement.","Parties agreed termination is mutual; regulatory approval unlikely by extended outside date of July 23, 2026.","Company to report Q4 and full-year 2025 financial results with strategic update on March 31, 2026.","LENSAR reaffirms focus on ALLY Robotic Cataract Laser System and market expansion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":102609,"accession_number":"0001193125-26-104937","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K/A","filed_at":"2026-03-13T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"LENSAR secures $9.2M revolving credit facility from Wells Fargo secured by brokerage account","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Revolving, non-purpose margin facility secured by a first-priority lien on a designated brokerage account at Wells Fargo.","Borrowing capacity up to $9.2 million based on collateral value in the Collateral Account.","Interest at fixed Treasury Yield plus margin or variable SOFR plus margin, at company election.","Credit agreement contains customary defaults including payment failure and collateral insufficiency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":102611,"accession_number":"0001193125-26-104194","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2026-03-12T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"LENSAR enters $50M revolving credit facility with Wells Fargo secured by brokerage account","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Revolving non-purpose margin credit facility up to $50M, secured by first-priority lien on a designated brokerage account at Wells Fargo.","Approximately $10M in collateral deposited; borrowings bear interest at Treasury Yield + margin or SOFR + margin.","Facility contains customary events of default including bankruptcy, failure to pay, or insufficient collateral value."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":102610,"accession_number":"0001193125-26-072059","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"LENSAR acquisition by Alcon faces FTC second request; closing expected H1 2026","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["LENSAR and Alcon continue cooperating with FTC on Second Request and review.","Transaction now expected to close in first half of 2026, subject to FTC approval.","Previous closing timeline not specified; this update indicates regulatory delay.","Press release furnished under Item 7.01 FD; no financial details revised."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118855,"accession_number":"0001193125-25-326777","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2025-12-19T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"LENSAR stockholders elect three Class II directors, ratify PwC as auditor at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Nicholas T. Curtis elected with 14,344,298 votes FOR, 1,101,660 WITHHELD, 2,067,913 broker non-votes.","Todd B. Hammer elected with 14,199,606 FOR, 1,246,352 WITHHELD, same broker non-votes.","Aimee S. Weisner elected with 14,303,359 FOR, 1,142,599 WITHHELD, same broker non-votes.","Ratification of PricewaterhouseCoopers LLP as auditor: 17,469,668 FOR, 32,629 AGAINST, 11,574 ABSTAINED.","Total voting power present at meeting: 17,513,871 votes, representing 88.07% of outstanding capital stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118854,"accession_number":"0001193125-25-268073","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LENSAR Q3 revenue $14.3M, net loss $3.7M; ALLY installed base grows 77% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $14.3M, +6% YoY; net loss $3.7M ($0.31/share) vs $1.5M loss in Q3 2024.","Adjusted EBITDA -$0.3M vs +$0.4M prior year; procedure volume +11% to 46,811.","18 ALLY systems placed in Q3; installed base of 185 ALLY systems (+77% YoY), total 425 (+20%).","Alcon acquisition expected to close Q1 2026; FTC review ongoing; $5.3M deal costs incurred."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":42410000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118853,"accession_number":"0001193125-25-245196","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2025-10-21T23:59:59+00:00","items":["5.08","8.01"],"status":"ready","headline":"LENSAR sets Dec 18 2025 annual meeting, contingent on pending Alcon merger not closing first","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual meeting scheduled for December 18, 2025; record date October 24, 2025.","Stockholder proposals and director nominations due by October 31, 2025.","Meeting canceled if Alcon Research merger closes before December 18.","If merger completes, LENSAR becomes wholly owned Alcon subsidiary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135390,"accession_number":"0000950170-25-104556","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LENSAR Q2 revenue up 10% to $13.9M; ALLY placements surge; Alcon merger on track","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2025 revenue $13.9M (+10% YoY); procedure volume up 23% to 52,100.","18 ALLY systems placed; ALLY installed base grew 107% to ~165; total installed base ~410 (+23% YoY).","Net loss improved to $1.8M ($0.15/share) from $9.0M ($0.79/share) in Q2 2024, driven by warrant liability change.","Adjusted EBITDA loss of $0.3M vs. $30K positive in prior year period.","Merger with Alcon received >99% shareholder approval; FTC review ongoing; expected close by year-end."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":28094000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":135389,"accession_number":"0000950170-25-092921","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"LENSAR stockholders approve merger with Alcon Research","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["15,983,846 votes for the merger, 26,033 against, 5,113 abstentions; 80.69% quorum.","Merger compensation proposal also approved: 14,369,161 for, 1,600,968 against.","Adjournment proposal approved but not needed due to sufficient votes for merger.","Merger will result in LENSAR surviving as a wholly owned subsidiary of Parent (Alcon).","Special meeting held July 2, 2025; merger agreement dated March 23, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":152376,"accession_number":"0001193125-25-125116","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2025-05-22T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"FTC issues Second Request for LENSAR-Alcon merger, extending HSR waiting period","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["LENSAR and Alcon each received a Second Request from the FTC regarding the pending merger.","The HSR waiting period is extended until 30 days after substantial compliance with the Second Request.","LENSAR continues to expect the merger to close in the second half of 2025.","Both companies intend to promptly respond and cooperate with the FTC review."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":152375,"accession_number":"0000950170-25-066375","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LENSAR Q1 revenue up 34% to $14.2M; net loss $27.3M on warrant liability adjustment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $14.2M (+34% YoY); recurring revenue $11.5M (81% of total).","Worldwide procedure volume 52,347 (+33% YoY); placed 14 ALLY Systems.","Net loss $27.3M ($2.32/share) vs $2.2M loss a year ago, driven by $4.2M merger costs and $22.5M warrant liability change.","Adjusted EBITDA improved to positive $0.2M from negative $1.3M in Q1 2024.","Installed base of ALLY Systems ~150; total combined LENSAR/ALLY base ~395 (+26% YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":14159000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":152374,"accession_number":"0000950170-25-066893","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K/A","filed_at":"2025-05-08T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"LENSAR Q1 revenue $14.2M (+34% YoY); net loss $27.3M on warrant liability","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $14.2M vs $10.6M in Q1 2024, driven by system sales and 33% procedure volume growth.","Net loss $27.3M ($2.32/share) vs $2.2M loss YoY; increase primarily from warrant liability revaluation due to 58% stock price rise.","Adjusted EBITDA was $0.2M vs -$1.3M in Q1 2024; includes $4.2M in Alcon merger-related costs.","Placed 14 ALLY systems in Q1; total installed base ~395 systems, up 26% YoY.","Recurring revenue $11.5M (81% of total); procedure volume 52,347 worldwide, up 33% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":14159000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":171212,"accession_number":"0001193125-25-060906","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2025-03-24T23:59:59+00:00","items":["1.01","7.01","8.01","9.01"],"status":"ready","headline":"Alcon acquires LENSAR for $14.00/share cash plus CVR up to $2.75, total ~$430M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Per-share consideration: $14.00 cash plus contingent value right (CVR) of up to $2.75 if 614,000 cumulative procedures achieved by Dec 31, 2027.","Total potential consideration of ~$430M; represents 24% premium to 30-day VWAP and 47% to 90-day VWAP.","North Run affiliates, representing ~45.8% of voting power, entered voting agreement to support the merger.","Transaction expected to close mid-to-late 2025, subject to regulatory approvals and LENSAR stockholder approval.","LENSAR's ALLY Robotic Cataract Laser System and Streamline software strengthen Alcon's cataract equipment portfolio."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":171211,"accession_number":"0000950170-25-028363","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LENSAR Q4 revenue $16.7M (+38% YoY); positive Adj. EBITDA; ALLY placements surge","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $16.7M, up 38% YoY; full-year revenue +27% YoY to ~$54M (implied).","Net loss $18.7M ($1.61/sh) driven by $17.6M warrant liability charge; Adjusted EBITDA positive $0.5M.","Placed 31 ALLY systems in Q4; total installed base ~385 (+26% YoY); 80+ ALLY placements in 2024.","Recurring revenue exceeded $40M in 2024 (+23% YoY); U.S. procedure market share >20% first time.","Worldwide procedure volumes grew 24% to nearly 170,000 in 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.73,"consensus_revenue_estimate":null,"consensus_revenue_actual":53494000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":188178,"accession_number":"0000950170-24-122790","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LENSAR Q3 revenue $13.5M (+38% YoY); 24 ALLY placements; adj. EBITDA positive","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $13.5M, up 38% YoY; procedure volume +29% worldwide.","Net loss $1.5M vs net income $2.6M a year ago due to $4.3M swing in warrant liability.","Placed 24 ALLY systems; installed base 355 systems (+20% YoY).","Adjusted EBITDA turned positive at $0.4M vs -$1.4M in Q3 2023.","U.S. market share of 19.9% (up 3.5pp); backlog of 24 systems pending installation."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":36763000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204676,"accession_number":"0000950170-24-093326","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["1.02","2.02","9.01"],"status":"ready","headline":"LENSAR Reports Q2 2024 Results with 17 ALLY Placements and Terminates Oertli Development Agreement","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2024 revenue $12.6M, up 5% YoY; net loss $9.0M vs $8.8M loss in Q2 2023.","Placed 17 ALLY Systems in Q2 2024, highest since launch; total installed base ~330 systems.","Worldwide procedure volume increased 19% to 42,203 in Q2 2024 from 35,349 in Q2 2023.","Terminated Development Agreement with Oertli Instrumente AG effective Aug 5, 2024, with no termination penalties.","Received MDR certification (CE Mark) and Taiwan FDA approval; first EU and SE Asia ALLY systems shipped."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.98,"consensus_revenue_estimate":null,"consensus_revenue_actual":23224000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":221516,"accession_number":"0000950170-24-058603","cik":1320350,"company_name":"LENSAR, Inc.","ticker":"LNSR","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"LENSAR stockholders elect O'Farrell and Winer as Class I directors, ratify PwC","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elizabeth G. O'Farrell received 13,650,553 votes FOR, 1,705,445 WITHHELD; Gary M. Winer received 13,322,586 FOR, 2,033,412 WITHHELD.","PricewaterhouseCoopers LLP ratified as independent auditor for FY2024 with 16,568,106 FOR, 134,822 AGAINST, 301,710 ABSTAIN.","Approximately 87.94% of total voting power (17,004,638 votes) represented at the meeting.","Directors elected to serve until the 2027 annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":71052408.28498292,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}